The August
A.S.H. newsletter arrived in my inbox this morning. Several snippets of
interest – my attention was particularly taken by the thingy on coagulation inhibitors. Nothing
really new, but it reminded me of that which I’d forgotten. I need to remind
myself about them
| Editor's Corner Keith Stewart, MBChB, MBA, acknowledges the hard work of every member of the “medical marvels” team – including Big Pharma. |
||
|
||
|
The Geography of Drug Approvals Why do regulatory agencies, such as the U.S. Food and Drug Administration and European Medicines Agency, look at the same data and get different results? A Cure for Congress? Jason Westin, MD, shares why he decided to run for Representative of the 7th Congressional District of Texas and how he’s navigating the challenges of balancing politics and patients. |
||
|
||
|
Patient Education: Understanding Inhibitors Produced in collaboration with the World Federation of Hemophilia, this tear sheet provides patients with information about the development, diagnosis, and treatment of hemophilia with inhibitors. |
||
|
||
|
The Society Pages A look at the latest promotions, grants, and awards in the hematology/oncology community. ASH Directions ASH selects outstanding trainees for award programs, announces honorific award winners, and more. Latest and Greatest NIH reverses decision to cap funding to individual laboratories, pembrolizumab trials halted after patient deaths, and more. On Location Highlights from the EHA Annual Congress, including anticoagulant therapy in older patients with VTE risk, polatuzumab vedotin combination in DLBCL, and more. |
||
|
||||
|
||||
|
Written in Blood The latest research from Blood, including: |
||||
|
Blood Advances in a Different Vein |
||||
|
Literature Scan Research from other top journals, including: |
||||
|
You Make the Call How would you treat a patient with aplastic anemia who refuses transfusions for religious reasons? |
No comments:
Post a Comment